Search results: Sage Journals

Open accessReview articleFirst published 2019

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia

José R. González-Porras, Bertrand Godeau, Monica Carpenedo

Therapeutic Advances in Hematology

Open accessCase reportFirst published March, 2021

Eltrombopag Can Achieve Treatment Free Remission as Upfront Therapy for Patient with Immune Thrombocytopenia

Khaldun Obeidat, Mohamad A Yassin

Blood & Plasma

Open accessResearch articleFirst published 2022

Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura

Zayar Oo, Kapilkumar Manvar, Jen Chin Wang

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published February, 2025

Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis

Gerard Gurumurthy, Filip Kisiel, Samantha Gurumurthy [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

Monica Carpenedo, Erminia Baldacci, Claudia Baratè [...]

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2021

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review

Nikki Agarwal, Ankit Mangla

Therapeutic Advances in Hematology

Open accessReview articleFirst published June, 2025

Management of Thrombocytopenia in SLE

Anil Kumar, Vineeta Shobha

Indian Journal of Rheumatology

Open accessReview articleFirst published 2020

The role of romiplostim for pediatric patients with immune thrombocytopenia

Hanny Al-Samkari, Rachael F. Grace, David J. Kuter

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published January, 2015

Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines,but unrelated to thrombocytopenia or thrombosis

C Lu, J Nossent

Lupus

Open accessReview articleFirst published 2019

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia

Hanny Al-Samkari, David J. Kuter

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2019

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia

José R. González-Porras, Bertrand Godeau, Monica Carpenedo

Therapeutic Advances in Hematology

Open accessCase reportFirst published March, 2021

Eltrombopag Can Achieve Treatment Free Remission as Upfront Therapy for Patient with Immune Thrombocytopenia

Khaldun Obeidat, Mohamad A Yassin

Blood & Plasma

Open accessResearch articleFirst published 2022

Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura

Zayar Oo, Kapilkumar Manvar, Jen Chin Wang

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published February, 2025

Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis

Gerard Gurumurthy, Filip Kisiel, Samantha Gurumurthy [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

Monica Carpenedo, Erminia Baldacci, Claudia Baratè [...]

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2021

Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review

Nikki Agarwal, Ankit Mangla

Therapeutic Advances in Hematology

Open accessReview articleFirst published June, 2025

Management of Thrombocytopenia in SLE

Anil Kumar, Vineeta Shobha

Indian Journal of Rheumatology

Open accessReview articleFirst published 2020

The role of romiplostim for pediatric patients with immune thrombocytopenia

Hanny Al-Samkari, Rachael F. Grace, David J. Kuter

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published January, 2015

Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines,but unrelated to thrombocytopenia or thrombosis

C Lu, J Nossent

Lupus

Open accessReview articleFirst published 2019

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia

Hanny Al-Samkari, David J. Kuter

Therapeutic Advances in Hematology